MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock upon...
$1,376K
Net cash provided by
(used in) financing...
$1,376K
Net increase
(decrease) in cash and cash...
-$10,374K
Canceled cashflow
$1,376K
Change in the fair value
of contingent...
$2,066K
Accounts payable
$1,631K
Stock based
compensation
$1,255K
Change in fair value of
debt, net
$490K
Depreciation and
amortization
$36K
Right of use assets,
operating leases and...
-$27K
Proceeds from maturities
of investments
$14,000K
Net cash used in
operating activities
-$9,928K
Net cash provided by
investing activities
-$1,781K
Canceled cashflow
$5,505K
Canceled cashflow
$14,000K
Effect of exchange rate
changes on cash
-$41K
Net loss
-$13,442K
Purchase of investments
$15,707K
Accrued expenses and
other current...
-$604K
Other assets
$486K
Prepaid expenses and
other current assets
$374K
Fair value
adjustment for warrants
-$291K
Amortization of discount on
available-for-sale investments
$236K
Purchase of property and
equipment
$74K
Back
Back
Cash Flow
source: myfinsight.com
Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics, Inc. (QNCX)